Key Pharmacokinetic and Pharmacodynamic Attributes of Tirzepatide The clinical success of tirzepatide relies on its distinctive pharmacokinetic and pharmacodynamic profile, which supports once-weekly dosing and sustained metabolic control
Changes in vision, while uncommon, may occur during treatment
[4] [5] MASLD exists on a spectrum from simple steatosis (fat accumulation without significant inflammation) to metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH), which involves inflammation and liver cell damage
Knowing this timeline allows patients to stick to their treatment plans, handle skipped doses, and see why regular medical checkups matter while undergoing therapy
Still, semaglutide remains a highly effective and accessible therapy, with a strong safety record and broader real-world use